Amicus Therapeutics is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. The company is currently conducting research in Gaucher, Fabry and Pompe diseases.
The Children’s Gaucher Research Fund is a non-profit organization, that raises funds to coordinate and support research aimed at finding a cure for Type 2 and Type 3 Gaucher disease.
The mission of The Compassionate Friends is to assist families in the positive resolution of grief following the death of a child and to provide information to help others be supportive.
Comprehensive Gaucher Treatment Center – Los Angeles – California
The Gauchers Association, UK, was formed in 1991 to meet the needs of those suffering from Gaucher disease. Its members are mainly in the UK and Ireland.
GOLD, is an international collaboration of scientific and medical associations, patient groups, and commercial organizations dedicated to improving the lives of all patients with a lysosomal disease.
The Lysosomal Storage Disease Network is a research consortium of scientists, laboratories, health care professionals and clinics working as networked centers of excellence to improve basic knowledge and understanding of lysosomal disorders.
The National Gaucher Foundation was founded in 1984 to meet the needs of those suffering from Gaucher disease. Its members are mainly in the United States.
NLM’s search service provides access to nine million citations in MEDLINE and Pre-MEDLINE (with links to participating on-line journals), and other related databases.
The National Organization for Rare Disorders (NORD) is a unique federation of voluntary health organizations dedicated to helping people with rare “orphan” diseases and assisting the organizations that serve them. NORD is committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and service.
National Tay-Sachs & Allied Diseases Association, Inc.